Genetic discoveries offer promising new clues into the roots of key diseases that target the esophagus, the complex tube that carries food from the mouth to the stomach.
... More
The FDA has approved a long-acting proton pump inhibitor (PPI) for once-daily treatment of gastroesophageal reflux disease, or GERD, according to an announcement by the drugmaker. Kapidex (generic name: dexlansoprazole) was approved for healing all grades of erosive esophagitis for up to eight weeks, for maintaining healing of erosive esophagitis for up to six months, ... More